microRNA Replacement Therapy
Press Releases

 
Press Releases
Date Title and Summary View
03-14-17 AUSTIN, Texas--(BUSINESS WIRE)-- Mirna Therapeutics, Inc. (Nasdaq: MIRN), a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2016 and provided a corporate update. Following its November 2016 decision to discontinue all research and ...
05-09-17 AUSTIN, Texas--(BUSINESS WIRE)-- Mirna Therapeutics, Inc. (Nasdaq:MIRN), a biopharmaceutical company, today reported financial results for the first quarter of 2017 and provided a corporate update. Following its late 2016 discontinuation of all research and development activities, the Com...
05-16-17 - Transaction Expected to Advance Synlogic's Innovative Platform for the Discovery and Development of Novel Synthetic Biotic™ Medicines - - Synlogic Closes $42 Million of Series C Preferred Stock Financing by Leading Biotechnology Investors - - Combined Company Well-Capitaliz...
Page: FirstPrevious ...
8
= add release to Briefcase
© 2017 Mirna Therapeutics, Inc. All Rights Reserved.